Shaheen says 27 states lack a $35 insulin cap, presses Senate to pass her INSULIN Act
In a video her office released Thursday, the New Hampshire Democrat argued that a federal cap would stop Americans in some states from paying thousands of dollars a year for insulin.
U.S. Sen. Jeanne Shaheen, D-N.H., released a video Thursday urging Congress to pass her INSULIN Act, saying 27 states do not cap monthly insulin costs at $35.
The bill, whose full name is the Improving Needed Safeguards for Users of Lifesaving Insulin Now Act, would cap out-of-pocket insulin costs at $35 a month for Americans with insurance, and her office said it would expand the effective price cap for people on Medicare. Shaheen's office described the bill as bipartisan.
"While some states have already taken steps to cap insulin costs at $35 or less, most haven't," Shaheen said in the video. "That means Americans in states such as South Dakota, Wyoming and Pennsylvania could be forced to pay thousands of dollars a year for the insulin they need to stay alive."
She argued that "the state you live in shouldn't determine whether you can afford your life-saving insulin," and said she has heard from students, families and health care providers who have had to choose between groceries and insulin.
According to her office, the bill advanced out of the Senate Health, Education, Labor and Pensions Committee in July, and companion legislation was introduced in the U.S. House in September. Her office said the measure is closer than ever to passing the Senate.
Shaheen is co-chair of the Senate Diabetes Caucus. Her office cited polling from the American Diabetes Association that it said found 40% of respondents who rely on insulin pay more than $150 a month for it, and 76% of respondents across political parties support a $35 limit on cost sharing for insulin.
This brief was drafted by AI from a public agency or political press release and published by The New England Signal. Why we use AI for stories like this one.